380 related articles for article (PubMed ID: 26851421)
21. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
22. Correlations Between Cutaneous Malignant Melanoma and Other Cancers: An Ecological Study in Forty European Countries.
Serrano PF; Serrano JL; Allam MF; Navajas RF
Int J Prev Med; 2016; 7():73. PubMed ID: 27217938
[TBL] [Abstract][Full Text] [Related]
23. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
24. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study.
Freedman DM; Zahm SH; Dosemeci M
BMJ; 1997 May; 314(7092):1451-5. PubMed ID: 9167561
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe.
Dal Maso L; Franceschi S; Lo Re A; La Vecchia C
Br J Cancer; 1999 Jan; 79(1):161-3. PubMed ID: 10408708
[TBL] [Abstract][Full Text] [Related]
26. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
27. Childhood Hodgkin's lymphoma, non-Hodgkin's lymphoma and factors related to the immune system: the Escale Study (SFCE).
Rudant J; Orsi L; Monnereau A; Patte C; Pacquement H; Landman-Parker J; Bergeron C; Robert A; Michel G; Lambilliotte A; Aladjidi N; Gandemer V; Lutz P; Margueritte G; Plantaz D; Méchinaud F; Hémon D; Clavel J
Int J Cancer; 2011 Nov; 129(9):2236-47. PubMed ID: 21170962
[TBL] [Abstract][Full Text] [Related]
28. The epidemiology of non-Hodgkin's lymphoma: why the increased incidence?
Palackdharry CS
Oncology (Williston Park); 1994 Aug; 8(8):67-73; discussion 73-8. PubMed ID: 7947004
[TBL] [Abstract][Full Text] [Related]
29. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study.
Cocco P; t'Mannetje A; Fadda D; Melis M; Becker N; de Sanjosé S; Foretova L; Mareckova J; Staines A; Kleefeld S; Maynadié M; Nieters A; Brennan P; Boffetta P
Occup Environ Med; 2010 May; 67(5):341-7. PubMed ID: 20447988
[TBL] [Abstract][Full Text] [Related]
30. The pattern of haematological and lymphoreticular malignancy in Zimbabwe.
Levy LM
Trop Geogr Med; 1988 Apr; 40(2):109-14. PubMed ID: 3406999
[TBL] [Abstract][Full Text] [Related]
31. Nutritional factors and the development of non-Hodgkin's lymphoma: a review of the evidence.
Davis S
Cancer Res; 1992 Oct; 52(19 Suppl):5492s-5495s. PubMed ID: 1394161
[TBL] [Abstract][Full Text] [Related]
32. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence.
Hartge P; Devesa SS
Cancer Res; 1992 Oct; 52(19 Suppl):5566s-5569s. PubMed ID: 1394175
[TBL] [Abstract][Full Text] [Related]
33. Incidence rates of lymphomas and environmental measurements of phenoxy herbicides: ecological analysis and case-control study.
Fontana A; Picoco C; Masala G; Prastaro C; Vineis P
Arch Environ Health; 1998; 53(6):384-7. PubMed ID: 9886156
[TBL] [Abstract][Full Text] [Related]
34. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Britton JA; Khan AE; Rohrmann S; Becker N; Linseisen J; Nieters A; Kaaks R; Tjønneland A; Halkjaer J; Severinsen MT; Overvad K; Pischon T; Boeing H; Trichopoulou A; Kalapothaki V; Trichopoulos D; Mattiello A; Tagliabue G; Sacerdote C; Peeters PH; Bueno-de-Mesquita HB; Ardanaz E; Navarro C; Jakszyn P; Altzibar JM; Hallmans G; Malmer B; Berglund G; Manjer J; Allen N; Key T; Bingham S; Besson H; Ferrari P; Jenab M; Boffetta P; Vineis P; Riboli E
Haematologica; 2008 Nov; 93(11):1666-77. PubMed ID: 18835833
[TBL] [Abstract][Full Text] [Related]
35. Screening for Celiac disease in Hodgkin and non-Hodgkin lymphoma patients.
Cil T; Altintaş A; Işikdoğan A; Paşa S; Bayan K; Batun S; Büyükbayram H
Turk J Gastroenterol; 2009 Jun; 20(2):87-92. PubMed ID: 19530040
[TBL] [Abstract][Full Text] [Related]
36. Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women.
Zhang Y; Holford TR; Leaderer B; Boyle P; Zahm SH; Owens PH; Morton LM; Zhang B; Zou K; Flynn S; Tallini G; Zheng T
Am J Epidemiol; 2004 Aug; 160(4):325-30. PubMed ID: 15286017
[TBL] [Abstract][Full Text] [Related]
37. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
Broccia G; Cocco P; Casula P;
Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
[TBL] [Abstract][Full Text] [Related]
38. Occupational exposure and malignant lymphoma.
Persson B
Int J Occup Med Environ Health; 1996; 9(4):309-21. PubMed ID: 9117190
[TBL] [Abstract][Full Text] [Related]
39. Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study.
Harrington DS; Ye YL; Weisenburger DD; Armitage JO; Pierson J; Bast M; Purtilo DT
Hum Pathol; 1987 Sep; 18(9):924-8. PubMed ID: 3497862
[TBL] [Abstract][Full Text] [Related]
40. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies.
Larsson SC; Wolk A
Eur J Cancer; 2011 Nov; 47(16):2422-30. PubMed ID: 21733676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
